Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options

Sponsor
New York Blood Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT02834572
Collaborator
(none)
236
1
2
18
13.1

Study Details

Study Description

Brief Summary

Young Black men who have sex with men (MSM) and transwomen in the US are affected by HIV at severely disproportionate rates. A key component of HIV prevention for communities at risk is diagnosing HIV infections through regular HIV testing. A significant proportion of young Black MSM and transwomen have not tested in the prior year. This research study seeks to address low HIV testing rates among young Black MSM and transwomen by testing a brief Internet-based HIV testing intervention optimized for mobile devices. The intervention takes advantage of the variety of HIV testing options now available, including the HIV self testing, couples-based HIV counseling and testing and traditional clinic-based testing and will provide men and transwomen with a tailored recommendation of their optimal HIV testing approach. The investigators are conducting a pilot randomized study among young Black MSM and transwomen followed for 6 months to estimate the intervention's potential efficacy in increasing HIV testing.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: All About Me
  • Behavioral: Control
N/A

Detailed Description

We are conducting a pilot study among 240 young Black MSM and transgender women randomized to the Intervention Arm (assessment and algorithm to deliver a tailored recommendation) or Control (assessment and standard HIV testing information) and followed for 6 months to estimate the intervention's potential efficacy in increasing HIV testing. After informed consent, participants are asked to provide contact information on the locator form. Then, participants complete a brief quantitative assessment including basic demographics, HIV testing history and other factors related to HIV testing. All participants, regardless of study arm, then receive information about each HIV testing method including how the tests are conducted (blood, oral sample), and availability of counseling and support. Participants then are randomized into 1 of the 2 study arms. A computer program will randomly assign each participant using randomly ordered block sizes of 4 and 6 and stratified by age (16-23, 24-29 years) to balance groups.

Participants assigned to the Intervention Arm will complete a brief quantitative assessment lasting approximately 2-3 minutes to assess those factors associated with HIV testing and thus are needed to complete the algorithm. They then receive the results of the HIV testing algorithm, presented as their personalized HIV testing approach. All participants will receive information on resources in New York City to test by all of these methods. The control participants are provided with the above information about each testing approach but without a recommended approach.

Study Design

Study Type:
Interventional
Actual Enrollment :
236 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options
Study Start Date :
Jun 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2017
Anticipated Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: All About Me

assessment and algorithm to provide participants with a tailored recommendation of their optimal HIV testing approach

Behavioral: All About Me
Assessment and algorithm to determine recommended HIV testing approach

Active Comparator: Control

HIV testing information

Behavioral: Control
HIV testing information

Outcome Measures

Primary Outcome Measures

  1. Number of participants reporting having an HIV test as assessed by questionnaire [3 months]

    Self-reported HIV test in the prior 3 months assessed by questionnaire

Secondary Outcome Measures

  1. Number of participants who are aware of HIV self-testing and couples based voluntary counseling and testing as assessed by questionnaire [3 months]

    Self-reported awareness of HIV self-testing and couples based voluntary counseling and testing assessed by questionnaire

  2. Number of intervention participants recommended a self-test who use a self-test as assessed by questionnaire [3 months]

    Self-reported use of self test among those recommended a self test - Intervention participants only

  3. Number of intervention participants recommended testing at a clinic who test at a clinic as assessed by questionnaire [3 months]

    Self-reported use of testing at a clinic among those recommended to test at a clinic - Intervention participants

  4. Number of intervention participants recommended couples testing who test using couples testing as assessed by questionnaire [3 months]

    Self-reported use of couples testing among those recommended to test using couples testing - Intervention only

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 29 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • male at birth;

  • self-identify as Black, African American, Caribbean Black, African Black or multiethnic Black;

  • able to read and respond in English;

  • between 16-29 years of age;

  • known to be HIV-infected;

  • insertive or receptive anal intercourse with a man or transwoman in the last 12 months;

  • reside in the New York City metropolitan area

Exclusion Criteria:
  • enrolled in any other HIV research study involving HIV testing

  • participant in an HIV vaccine trial

  • currently taking pre-exposure prophylaxis

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York Blood Center New York New York United States 10065

Sponsors and Collaborators

  • New York Blood Center

Investigators

  • Principal Investigator: Beryl Koblin, PhD, NY Blood Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beryl Koblin, Ph, D., Principal Investigator, New York Blood Center
ClinicalTrials.gov Identifier:
NCT02834572
Other Study ID Numbers:
  • 473699-41
First Posted:
Jul 15, 2016
Last Update Posted:
Apr 25, 2017
Last Verified:
Apr 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided

Study Results

No Results Posted as of Apr 25, 2017